🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07676552
Starting soon Not applicable

Rectointercostal Plane Block (RICPB) for Laparoscopic Cholecystectomy

NCT07676552 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-01
Last updated
2026-07-02

Condition(s) studied

CholelithiasisPostoperative Pain

Investigational drug(s) / intervention(s)

Rectointercostal Plane BlockPort-Site Local Anesthetic Infiltration

Rectointercostal Plane Block: Ultrasound-guided unilateral right-sided rectointercostal plane block (RICPB) will be performed at the end of surgery before emergence from anesthesia. A total of 30 mL of 0.25% bupivacaine will be injected into the rectointercostal plane under ultrasound guidance.

Port-Site Local Anesthetic Infiltration: Conventional port-site local anesthetic infiltration will be performed at the end of surgery according to the study protocol to provide postoperative analgesia.

Study summary

This prospective randomized controlled trial is designed to evaluate the analgesic efficacy of ultrasound-guided rectointercostal plane block (RICPB) in patients undergoing elective laparoscopic cholecystectomy. Patients will be randomized to receive unilateral right-sided RICPB at the end of surgery. Postoperative opioid consumption, Numeric Rating Scale (NRS) pain scores, and postoperative complications will be assessed to determine the effectiveness of RICPB in postoperative pain management.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 65 years * American Society of Anesthesiologists (ASA) physical status I-III * Scheduled for elective laparoscopic cholecystectomy * Body mass index (BMI) between 18 and 35 kg/m² * Ability to understand the study procedures and provide written informed consent Exclusion Criteria: * Refusal to participate or inability to provide informed consent * Known allergy or hypersensitivity to local anesthetics, opioids, or study medications * Chronic opioid use or chronic pain syndrome * Coagulation disorders or ongoing anticoagulant therapy * Infection at the planned injection site * Pregnancy or breastfeeding * Cognitive impairment or inability to communicate pain scores * Severe hepatic, renal, cardiac, or respiratory disease judged by the investigator to interfere with study participation * Conversion from laparoscopic to open surgery * Previous upper abdominal surgery that may interfere with the block technique or pain assessment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Koç University Hospital Istanbul Istanbul

More Koç University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07676552 on ClinicalTrials.gov ↗ ← All trials in Turkey